Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Prediction: This Is What Eli Lilly Stock Will Do Next July 26, 2024 — 07:45 am EDT Written by Adam Spatacco for The Motley Fool -> ...

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the ...

Interpret this new move as being bullish for Eli Lilly's stock. But remember that until it has an approval from regulators in hand, running clinical trials to test its drug is an expense, not revenue.

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring sales thanks to its dominance in the high-growth weight loss drug market ...

JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.

Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split) September 21, 2024 — 09:53 am EDT Written by Adam Spatacco for The Motley Fool -> ...